UNDIFFERENTIATED SARCOMA
Clinical trials for UNDIFFERENTIATED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED SARCOMA trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells join forces with checkpoint drugs to fight hard-to-treat sarcomas
Disease control Recruiting nowThis early-phase study tests whether giving specially engineered immune cells (HER2-CAR T cells) together with an immune checkpoint inhibitor (pembrolizumab or nivolumab) is safe and can help people with advanced sarcoma. About 25 participants will receive chemotherapy to prepare…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
New hope for rare childhood cancers: drug trial targets stubborn sarcomas
Disease control Recruiting nowThis study is testing a drug called lurbinectedin in people aged 10 and older whose solid tumors (like Ewing sarcoma) have come back or not responded to standard treatment. The goal is to see if the drug is safe and can shrink tumors or delay their growth. Participants must have …
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:40 UTC